The Influence of Human N-Acetyltransferase Genotype on the Early Bactericidal Activity of Isoniazid
Authors:
Open Access
- 15 November 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 39 (10) , 1425-1430
Abstract
The elimination of isoniazid is subject to the influence of the N-acetyltransferase 2 (NAT2) genotype, and individuals may be homozygotic slow, heterKeywords
This publication has 12 references indexed in Scilit:
- American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2003
- The Early Bactericidal Activity of Isoniazid Related to Its Dose Size in Pulmonary TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Trimodality of Isoniazid Elimination: Phenotype and Genotype in Patients With TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Low Antituberculosis Drug Concentrations in Patients with AIDSAnnals of Pharmacotherapy, 1996
- High-performance liquid chromatographic determination of isoniazid, acetylisoniazid and hydrazine in biological fluidsJournal of Chromatography B: Biomedical Sciences and Applications, 1995
- A simple salting out procedure for extracting DNA from human nucleated cellsNucleic Acids Research, 1988
- Experimental Evaluation of Efficacy1988
- The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosisTubercle, 1984
- Clinical Pharmacokinetics of IsoniazidClinical Pharmacokinetics, 1979
- A sensitive urine-test method for monitoring the ingestion of isoniazid.Journal of Clinical Pathology, 1977